Ep 1: Get in the CAR loser, we're curing cancer

This podcast delves into the exciting world of cancer immunotherapy, focusing on the evolution of cancer vaccines and the recent surge of cell-based therapies. It begins with a brief historical overview, highlighting the discovery of Coley’s toxin, which marked the earliest attempts at cancer vaccination. It then dives into the complexities of therapeutic vaccines, underscoring the challenges presented by cancer cells' ability to evade the immune system. The conversation transitions to cell-based therapies, which involve extracting and modifying immune cells outside the body to target cancer cells directly. It then highlights CAR T Cell therapy’s effectiveness against blood cancers and the ongoing research to improve its efficacy against solid tumors. Then it delves into the potential of IL-15, a cytokine that seems to enhance CAR T-cell function and longevity, and explores the role of NK cells as a potential alternative platform for CAR engineering. Finally, the dialogue addresses the crucial ethical considerations surrounding the rapid advancement of personalized medicine and the importance of ensuring equitable access to these transformative therapies. The purpose is to educate the audience about the evolution of cancer immunotherapy and the potential of cell-based therapies to revolutionize cancer treatment.